[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"upper-limb\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:upper-limb":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,46,69,93,126,162],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100557578","regulatory-clearance-of-the-glide-control-strategy-for-upper-limb-prostheses-100557578",false,"NCT06539936","Regulatory Clearance of the Glide Control Strategy for Upper Limb Prostheses","Inclusion Criteria:\n\n* Trans-radial unilateral limb loss\n* Candidate for a multi-articulated myoelectric hand prosthesis as determined by the study prosthetist\n* Minimal residual limb length for myoelectric control as determined by the clinical team\n* Age of 18 years or greater\n\nExclusion Criteria:\n\n* Patients with a residual limb that is unhealed from the amputation surgery\n* Patients with easily damaged or sensitive skin who would not tolerate EMG electrodes\n* Unhealed wounds\n* Significant cognitive deficits as determined upon clinical evaluation\n* Significant neurological deficits as determined upon clinical evaluation\n* Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation\n* Uncontrolled pain or phantom pain impacting full participation in the study as determined upon clinical evaluation\n* Serious uncontrolled medical problems as judged by the project therapist","ALL","18 Years",{"count":18,"type":19},7,"ESTIMATED","INTERVENTIONAL",[22],"NA","The investigators will test the following hypothesis: Use of Glide results in improved functional performance, satisfaction, and usage metrics as compared to use of a standard Direct Control (DC) prosthesis.\n\nThis study will compare the use of Glide \\[Experimental\\] prosthesis with a DC \\[Standard\\] prosthesis in a clinical setting and in unsupervised daily activity. We will follow a multiple baseline design, specifically an AB design. Each of the subjects will use the Experimental and Standard systems over a total of 24-weeks. The A phase is the baseline phase where the DC prosthesis will be used, and the B phase will be the treatment phase where the Glide prosthesis will be used. Participants will undergo an A phase of either 10-weeks, 12-weeks, or 14-weeks duration, with the remaining 14-, 12-, or 10-weeks of the study being dedicated to the B phase.",[25,26],"Amputation","Upper Limb",[28,29,30,31,32],"amputation","upper limb","myoelectric control","prosthesis","glide","RECRUITING","2026-05-27",{"date":36,"type":37},"2026-05-29","ACTUAL",{"date":39,"type":37},"2024-09-16",{"date":41,"type":19},"2027-03-31",{"name":43,"class":44},"Infinite Biomedical Technologies","INDUSTRY",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":20,"phases":55,"briefSummary":56,"conditions":57,"keywords":58,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":45},"100507518","study-of-efficacy-of-the-myotrain-system-in-a-population-of-individuals-with-trans-radial-limb-loss-100507518","NCT05888428","Study of Efficacy of the MyoTrain System in a Population of Individuals With Trans-radial Limb Loss","Regulatory Clearance of a Rehabilitation System for Individuals With Upper Limb Loss","Inclusion Criteria:\n\n* Trans-radial unilateral limb loss\n* Candidate for a 2+ degree-of-freedom myoelectric pattern recognition prosthesis as determined by prosthetist\n* Fluent in English\n* Age of 18 years or greater\n\nExclusion Criteria:\n\n* Prior experience with pattern recognition control\n* Patients with a residual limb that is unhealed from the amputation surgery\n* Patients with easily damaged or sensitive skin who would not tolerate EMG electrodes\n* Unhealed wounds\n* Significant cognitive deficits as determined upon clinical evaluation\n* Significant neurological deficits as determined upon clinical evaluation\n* Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation\n* Uncontrolled pain or phantom pain impactive full participation in the study as determined upon clinical evaluation\n* Serious uncontrolled medical problems as judged by the project therapist",{"count":54,"type":19},16,[22],"The investigators propose to evaluate the efficacy of MyoTrain in a prospective clinical study involving 16 individuals with trans-radial upper-limb loss over a period of 206 days. These individuals will be randomized to Group A (Control Group using standard motor imagery training) and Group B (who are provided the MyoTrain system).\n\nThe investigators will test three hypotheses:\n\n1. The use of MyoTrain results in skills transference to control of the final prosthesis\n2. The virtual outcome measures in MyoTrain are correlated with real-world functional outcome measures\n3. The use of MyoTrain results in improved clinical outcomes as measured by functional, subjective and usage metrics\n\nFollowing a baseline functional assessment, participants will undergo a 30-day pre-prosthetic training period specific to their assigned Group. After this training period, participants will receive their prosthetic device and occupational therapy consistent with the current clinical care standard, after which they will again undergo clinical assessment. Post-device delivery, participants will then complete 3 56-day blocks of at-home prosthesis use, in between which they will return to clinic for assessment.",[25,26],[28,29,59,60,31],"myoelectric","training","2025-10-27",{"date":63,"type":37},"2025-10-29",{"date":65,"type":37},"2024-02-02",{"date":67,"type":19},"2026-08-31",{"name":43,"class":44},{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":4,"eligibilityCriteria":74,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":75,"enrollmentInfo":76,"targetDuration":4,"studyType":20,"phases":78,"briefSummary":79,"conditions":80,"keywords":4,"overallStatus":83,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":90,"locationsCount":4},"100605659","analysis-of-neuromodulation-as-a-complementary-treatment-to-evidence-based-clinical-intervention-in-subjects-with-musculoskeletal-pathology-of-the-upper-limb-a-double-blind-randomized-clinical-trial-100605659","NCT07165392","Analysis of Neuromodulation as a Complementary Treatment to Evidence-based Clinical Intervention in Subjects With Musculoskeletal Pathology of the Upper Limb: a Double-blind Randomized Clinical Trial","Inclusion Criteria:\n\n* Participants in the study will be men and women of working age, diagnosed with musculoskeletal disorders of the upper limb, and who have not yet received physical therapy.\n\nExclusion Criteria:\n\n* Have undergone surgery.\n* Those who refuse to participate in this study.\n* Patients who present muscular atrophy in the upper limb due to a pathology of the latter.\n* Medical conditions that are contraindications for neuromodulation therapy","60 Years",{"count":77,"type":19},120,[22],"This project aims to analyze the use of neuromodulation within a treatment protocol for musculoskeletal conditions of the upper limb, as well as to determine the difference between two and three sessions per week. Study participants will be divided into four intervention groups: the first will receive two sessions per week for a period of six months, while the second will receive three sessions per week for the same period. The treatment protocol will consist of therapeutic physical exercise focused on the muscles and joints of the lower limb, stretching of the involved muscles, and neuromodulation of the brachial plexus nerve root, which innervates the affected structures. The third and fourth intervention groups will receive the same treatment as mentioned above, but without neuromodulation. The third group will receive three sessions per week, while the second group will receive two sessions per week. Two different types of measurement variables will be used: objective variables will be used to measure range of motion and muscle strength. Subjective variables will also be used through validated questionnaires, covering physical activity, health-related quality of life, upper limb function, and a visual analog scale for pain perception.",[81,26,82],"Neuromodulation","Musculoskeletal Disorders","NOT_YET_RECRUITING","2025-09-02",{"date":86,"type":37},"2025-09-10",{"date":88,"type":19},"2025-10-01",{"date":41,"type":19},{"name":91,"class":92},"University of Malaga","OTHER",{"id":94,"slug":95,"hasResults":11,"nctId":96,"briefTitle":97,"officialTitle":98,"acronym":4,"eligibilityCriteria":99,"healthyVolunteers":11,"sex":15,"minAge":100,"maxAge":4,"enrollmentInfo":101,"targetDuration":4,"studyType":103,"phases":4,"briefSummary":104,"conditions":105,"keywords":111,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":45},"100602251","the-effects-of-a-dynamic-arm-support-in-daily-life-100602251","NCT07121075","The Effects of a Dynamic Arm Support in Daily Life","The Effects of a Dynamic Arm Support in Daily Life. A Mixed Methods Study Including the Different Components of the ICF","Inclusion Criteria:\n\n* Age: 16 and oler\n* Being able to understand and comprehend test instructions\n* Using a DAS from Focal Meditech (Balancer, Flowing, Dowing, Gowing 2 or Top Help)\n\nExclusion Criteria:\n\n\u002F","16 Years",{"count":102,"type":19},50,"OBSERVATIONAL","The goal of this mixed method study is to learn about how a dynamic arm support device (DAS) helps people with everyday activities. The study focuses on people with neuro(-muscular) conditions, age 16 and older. The research questions that are formulated, are:\n\n* How does a person experience their daily activities, with and without a DAS?\n* What are the contextual (external and personal) factors that influence the use of a DAS?\n\nParticipants will take part in three testing sessions. In each session, they must complete a few questionnaires and participate in an interview. The first time, without DAS. In the second and third session, they will be using their DAS (resp. 3 to 4 weeks and 3 months). The data collection will be executed by phone, digital questionnaires and\u002For paper.",[106,107,108,109,110,26],"Neuromuscular Disease","Neuromuscular Disability","Assistive Technology","Activities of Daily Living","Occupational Therapy",[112,113,114,115,116],"dynamic arm support","dynamic arm support device","ICF","daily life","outcome measures","2025-08-12",{"date":119,"type":37},"2025-08-13",{"date":121,"type":37},"2024-12-02",{"date":123,"type":19},"2026-08",{"name":125,"class":92},"Hasselt University",{"id":127,"slug":128,"hasResults":11,"nctId":129,"briefTitle":130,"officialTitle":130,"acronym":4,"eligibilityCriteria":131,"healthyVolunteers":11,"sex":15,"minAge":132,"maxAge":133,"enrollmentInfo":134,"targetDuration":4,"studyType":20,"phases":136,"briefSummary":137,"conditions":138,"keywords":146,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":153,"lastUpdatePostDateStruct":154,"startDateStruct":156,"completionDateStruct":158,"leadSponsor":160,"locationsCount":45},"100567889","additional-effects-of-kinesio-taping-along-with-conservative-physical-therapy-on-upper-limb-function-range-of-motion-and-spasticity-in-the-patients-with-subacute-stroke-100567889","NCT06674057","Additional Effects of Kinesio-Taping Along with Conservative Physical Therapy on Upper Limb Function, Range of Motion and Spasticity in the Patients with Subacute Stroke","Inclusion Criteria:\n\n* Age group: 40-65 years onwards\n* Both males and females\n* Patients with history of diagnosed stroke and lie within subacute stage of stroke\n* MAS scale score of 1\\_2\n\nExclusion Criteria:\n\n* Any congenital deformities\n* cognitive deficits\n* Fractures\n* Upper limb surgery","40 Years","65 Years",{"count":135,"type":19},40,[22],"A randomized control trial will be done on diagnosed stroke patients of subacute stage in Fauji Foundation Hospital Rawalpindi and leading edge physical therapy and rehabilitation clinic.The purpose of the study is to determine Additional Effects of Kinesio-Taping along with conservative Physical Therapy on upper limb function, Range of motion and Spasticity in the patients with Subacute Stroke. The conservational physical therapy includes Passive and active ROMs 25 repetitions each, 3 times per week. PNF stretching (hold relax) for spastic muscles for 20 repetitions with a 10 second hold and 10 second relaxation of the muscle group 3 times per week.\n\nD1 flexion and extension for 20 repetitions 3 times per week. Kinesio tape 3 times per week. (Anchor opposed to effected compartment to provide facilitation and sustained stretch). with srtrngth training included in week 3-6 with a resistance band of medium resistance.\n\ntreatment time will be 30 minutes on alternate days for six weeks.",[139,26,140,141,142,143,144,145],"Subacute Stroke","Range of Motion","Spasticity","CVA (Cerebrovascular Accident)","KINESIOTAPING","Stroke","Function",[147,148,149,150,151,152],"Stroke.","subacute stroke","kinesio taping","proprioceptive neuromuscular facilitation","Upper limb function.","range of motion","2024-11-04",{"date":155,"type":37},"2024-11-05",{"date":157,"type":37},"2024-06-20",{"date":159,"type":19},"2025-01-20",{"name":161,"class":92},"Foundation University Islamabad",{"id":163,"slug":164,"hasResults":11,"nctId":165,"briefTitle":166,"officialTitle":166,"acronym":167,"eligibilityCriteria":168,"healthyVolunteers":11,"sex":15,"minAge":169,"maxAge":4,"enrollmentInfo":170,"targetDuration":4,"studyType":103,"phases":4,"briefSummary":172,"conditions":173,"keywords":4,"overallStatus":83,"whyStopped":4,"lastUpdateSubmitDate":176,"lastUpdatePostDateStruct":177,"startDateStruct":179,"completionDateStruct":181,"leadSponsor":183,"locationsCount":4},"100552419","tailoring-upper-limb-exercise-advice-for-people-with-parkinson-disease-100552419","NCT06472843","Tailoring Upper Limb Exercise Advice for People With Parkinson Disease","ICEBERG","Inclusion Criteria:\n\n* Adults over 19 with a clinical diagnosis of PD.\n\nExclusion Criteria:\n\n* Medical contraindication to aerobic exercise, such as unstable cardiovascular disease, or physical disability that precludes arm exercise.\n* Individuals will be excluded if, upon screening with the Canadian Society for Exercise Physiology (CSEP) Get Active Questionnaire and International Physical Activity Questionnaire Short Form (IPAQ-SF) a need for further evaluation before exercise is identified","19 Years",{"count":171,"type":19},20,"The investigators will explore the impact of hand cycling, on hand function in people with Parkinson's Disease (PD). The study will compare the effects of two different hand cycling approaches-steady-state and interval efforts-on improving hand dexterity in people with PD. Conducted as a clinical trial, it aims to understand if a single session of hand cycling can temporarily enhance hand function and if the nature of the exercise influences the benefit.",[174,26,175],"Parkinson Disease","Aerobic Exercise","2024-06-18",{"date":178,"type":37},"2024-06-25",{"date":180,"type":19},"2024-07-01",{"date":182,"type":19},"2024-09",{"name":184,"class":92},"University of British Columbia"]